Benzinga | May 25, 2021 11:30AM EDT

Humacyte CEO Dr. Laura Niklason Says Co. Has Phase 3 Trials Underway For Vascular Trauma And Kidney Failure, Says These Are First Two Conditions Co. Anticipates Gaining Approval For

https://www.youtube.com/watch?v=8lbZJjeH2MA